On Monday, Scynexis Inc (NASDAQ: SCYX) opened higher 16.50% from the last session, before settling in for the closing price of $0.7. Price fluctuations for SCYX have ranged from $0.66 to $2.29 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 46.02% over the past five years. Company’s average yearly earnings per share was noted 20.45% at the time writing. With a float of $37.02 million, this company’s outstanding shares have now reached $39.02 million.
Let’s look at the performance matrix of the company that is accounted for 28 employees. In terms of profitability, gross margin is 100.0%, operating margin of -1526.34%, and the pretax margin is -1157.27%.
Scynexis Inc (SCYX) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Scynexis Inc is 5.13%, while institutional ownership is 30.65%. The most recent insider transaction that took place on Dec 18 ’24, was worth 5,792. Before that another transaction happened on Dec 18 ’24, when Company’s 10% Owner proposed sale 128,957 for $1.23, making the entire transaction worth $158,617.
Scynexis Inc (SCYX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.45% per share during the next fiscal year.
Scynexis Inc (NASDAQ: SCYX) Trading Performance Indicators
Check out the current performance indicators for Scynexis Inc (SCYX). In the past quarter, the stock posted a quick ratio of 5.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach 0.58 in one year’s time.
Technical Analysis of Scynexis Inc (SCYX)
Scynexis Inc (NASDAQ: SCYX) saw its 5-day average volume 0.34 million, a positive change from its year-to-date volume of 0.17 million. As of the previous 9 days, the stock’s Stochastic %D was 59.09%.
During the past 100 days, Scynexis Inc’s (SCYX) raw stochastic average was set at 32.45%, which indicates a significant decrease from 93.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0444 in the past 14 days, which was lower than the 0.0639 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8281, while its 200-day Moving Average is $1.0818. Nevertheless, the first resistance level for the watch stands at $0.8651 in the near term. At $0.9112, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.9924. If the price goes on to break the first support level at $0.7378, it is likely to go to the next support level at $0.6566. Assuming the price breaks the second support level, the third support level stands at $0.6105.
Scynexis Inc (NASDAQ: SCYX) Key Stats
There are currently 39,020K shares outstanding in the company with a market cap of 31.96 million. Presently, the company’s annual sales total 3,750 K according to its annual income of -21,290 K. Last quarter, the company’s sales amounted to 260 K and its income totaled -5,390 K.
